Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
Findings seen in double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy
Clinical briefs for Friday, July 23
By
Alicia Lasek
Jul 23, 2021
Without fingerprinting, senior living workers barred from providing direct care … Fauci: Vaccinated people ‘might want to consider’ wearing masks indoors as COVID-19 cases surge … Continuing pimavanserin...
Parkinson’s drug shows some promise for treating Alzheimer’s psychosis
By
Kimberly Marselas
Feb 21, 2018
A drug approved for use in controlling hallucinations and delusions in Parkinson’s patients showed mix results in a trial among Alzheimer’s sufferers.